Skip to main content

Table 3 Characteristics of the patients (N = 4,946)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

  Patients (n = 4,946)
Age (mean, standard deviation) 43.9 (15.7)
> = 55 years (%) 25.4
Sex ratio (male:female) 1.3
WHO regions (%)  
 Africa 52.9
 America 0.7
 Eastern Europe 33.8
 Pacifica 1.6
 South East Asia 11.0
Diagnostic: CML (%) 91.4
Initial Phase (%)  
 Chronic 84.7
 Accelerated 13.3
 Blast crisis 2.0
Status (%)  
 Active 70.5
 Closed 27.5
 Denied 2.0
Duration of follow up (month; mean, standard deviation) 25.8 (25.9)
\